SADC E8 Inaugural Research Webinar - Malaria importation and the need for improved surveillance in E8 region, 8 December 2020
The Southern Africa Development Community Malaria Elimination Eight Initiative (SADC E8) is a regional collaboration established by SADC Ministers of Health in 2009. The E8 mandate is to coordinate and execute a regional malaria elimination strategy aimed at achieving the historic goal of eliminating malaria in southern Africa.
Due to the high degree of interconnectedness within the region, countries that have reduced malaria to low levels face the challenge of persistent importation of parasites by cross-border travelers from neighboring countries with higher rates of malaria infection.
This webinar aims to address the role of E8 malaria border posts and the need for improved surveillance to reduce cross border transmission across the E8 region.
Presentations:
1. Access to malaria prevention, diagnosis and treatment in border areas of E8 countries: results from an evaluation of malaria border posts in second line countries (Prof Immo Kleinschmidt, Mukosha Chisenga)
2. Plasmodium genomics as a surveillance tool for monitoring local malaria transmission networks and importation in Northern Namibia (Prof Davis Mumbengegwi)
3. Antimalarial Drug Resistance Surveillance, Primaquine and E8 malaria border posts in South Africa (Dr Jaishree Raman)
Register in advance for this webinar:
https://us02web.zoom.us/webinar/register/WN_-s-Q3zMfQGOOE-FjGUvMbQ
Articles
13Th Edition Of The Edctp Forum To Take Place In Madrid, Spain, From 5 To 9 April 2027
We are delighted to announce that the 13th edition of the EDCTP Forum will be celebrated on 5-9 April 2027, at IFEMA Palacio Municipal in Madrid, Spain.
The event will be co-hosted by the Instituto de Salud Carlos III (ISCIII) under the Spanish Ministry of Science, Innovation and Universities and the Fundación CSAI (FCSAI) under the Ministry of Health, and is co-organised by Global Health EDCTP3 and the EDCTP Association.
Over the past two decades, the biennial European & Developing Countries Clinical Trials Partnership (EDCTP) Forum has evolved to become a cornerstone event for global health research, bringing together leading voices advancing the fight against infectious diseases in sub-Saharan Africa. It showcases the latest scientific breakthroughs, highlights impactful capacity-building efforts, and creates a space for vibrant cross-regional collaboration.
The EDCTP Forum 2027 expects to convene 1,500 participants and stakeholders, from researchers, universities and clinicians to governments, regional bodies, civil society, regulators, and public and private R&D partners, drawing participation primarily from Africa and Europe.
Dr Tuelo Mogashoa Becomes First Tagendi Phd Graduate
Botswana-born scientist Dr Tuelo Mogashoa, a PhD Fellow in the ‘Addressing Gender and Diversity Regional Gaps in Clinical Research Capacity’ (TAGENDI) programme, has successfully defended her PhD in Molecular Biology (Tuberculosis Genomics) at Stellenbosch University. Her virtual oral examination, held on 12 January 2025, marked the culmination of years of research and training.
Her doctoral thesis, titled “Rifampicin- resistant tuberculosis: an emerging threat to human health in Botswana,” addresses one of the most pressing challenges in TB control.
Dr Mogashoa is the first of seven PhD fellows from the inaugural TAGENDI cohort to complete her doctoral studies. The TAGENDI fellowship, implemented under the Trials of Excellence in Southern Africa (TESA) Network, is part of a dedicated PhD fellowship scheme launched by EDCTP2 in 2020 to support women in health research across sub-Saharan Africa. Coordinated by the EDCTP Networks of Excellence, the initiative received funding from the UK National Institute for Health and Care Research (Department of Health and Social Care).
As part of her PhD requirements, Dr Mogashoa was expected to produce four manuscripts, with at least two accepted in peer-reviewed journals. She has exceeded this requirement, publishing three peer-reviewed articles from her doctoral work, with a fourth manuscript currently under review.
Her journey highlights the transformative impact of long-term investment in research training, mentorship, and gender equity. As she moves into the next phase of her career, her work promises to make a meaningful contribution to improving TB diagnosis, treatment, and control.
More information:
- Dr Tuelo Mogashoa Successfully Defends PhD in TB Genomics
- Tuelo’s journey: building Botswana’s capacity for cutting-edge health research
Prof. Novel Chegou Elected As Fellow Of The African Academy Of Sciences
Prof. Novel Chegou, EDCTP Senior Fellow and Acting Head of the Division of Immunology at the Faculty of Medicine and Health Sciences, Stellenbosch University, has been elected as a Fellow of the African Academy of Sciences. This important achievement recognises his scientific leadership and impactful research on tuberculosis, particularly his work on biomarkers to improve diagnosis and patient care in resource-limited settings.
Read more